iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

SPARC Establishes US Subsidiary SPARCLIFE Inc. for Clinical Trial Oversight

26 Sep 2023 , 03:22 PM

Sun Pharma Advanced Research Company (SPARC) establishes subsidiary SPARCLIFE Inc. in Delaware, US, according to an exchange filing. SPARCLIFE, Inc., incorporated on September 25, 2023, with 5,000 authorized Common Stock shares valued at USD 0.001 each.

The objective is to utilize SPARCLIFE to manage and oversee global clinical trials through a team of professionals based in the US. Acquisition cost: 50 shares of Common Stock acquired for USD 50,000 in cash.

For feedback and suggestions, write to us at editorial@iifl.com
 

Related Tags

  • news
  • SPARC
  • SPARCLIFE
  • Top News
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp